CEBINA Bridge Capital has entered into a collaboration agreement – DANUBE LABS – with CEBINA GmbH and Evotec International GmbH for the purpose of identifying and supporting pharmaceutical drug discovery projects originating from universities, research institutes and other entities in Central and Eastern Europe with each project having specially agreed terms between the parties on the split of participation in any successful end product.